Original Articles: Autoimmunity and Clinical Immunology
To add the references below to your reference management program: 1. Download the file; 2. Open your reference management program or EndNote; 3. Select File and import |
73 Articles |
-
Emollients for prevention of atopic dermatitis; 5-year findings from the BEEP randomised trial
Bradshaw, L.E., Wyatt, L.A., Brown, S.J., et al. Allergy. First published: 19 October 2022
-
Delayed type hypersensitivity reactions to various allergens may differently model inflammatory skin diseases
Pavel, A.B., Del Duca, E., Cheng, J., et al. Allergy. First published: 30 September 2022
-
Resensitisation in suspected penicillin allergy
Doña, I., Guidolin, L., Bogas, G., et al. Allergy. First published: 06 September 2022
-
Exposure to avian coronavirus vaccines is associated with increased levels of SARS-CoV-2-cross-reactive antibodies
Ardicli, O, Carli, KT, Satitsuksanoa, P, et al. et al. Allergy. First published: 23 July 2022
-
Personalized diagnostic approach and indirect quantification of extravasation in human anaphylaxis
Nuñez-Borque, E., Betancor, D., Carlos, P.-V., et al. Allergy. First published: 16 July 2022
-
T cell recovery and evidence of persistent immune activation 12 months after severe COVID-19
Taeschler, P., Adamo, S., Deng, Y., et al. Allergy. First published: 14 May 2022
-
Comparing the levels of CTLA-4 dependent biological defects in patients with LRBA deficiency and CTLA-4 insufficiency
Catak, M.C., Akcam, B., Bilgic Eltan, S., et al. Allergy. First published: 01 May 2022
-
Real-life evaluation of molecular multiplex IgE test methods in the diagnosis of pollen associated food allergy
Luisa, D, Bellinda, N, Rohrhofer, J, et al. Allergy. First published: 29 Apr 2022
-
Effect of BTN162b2 and Coronavac boosters on humoral and cellular immunity of individuals previously fully vaccinated with Coronavac against SARS-CoV-2: A longitudinal study
Kuloğlu, Z.E., El, R., Guney-Esken, et al. Allergy. First published: 19 April 2022
-
Methylation risk scores for childhood aeroallergen sensitization: Results from the LISA birth cohort
Kilanowski, A., Chen, J., Everson, T., et al. Allergy. First published: 19 April 2022
-
Development of the cold urticaria activity score
Ahsan, D. M., Altrichter, S., Gutsche, A., et al. Allergy. First published: 11 April 2022
-
Single low-dose exposure to cow’s milk at diagnosis accelerates cow’s milk allergic infants’ progress on a milk ladder programme
d’Art, Y.M., Forristal, L., Byrne, A.M., et al. Allergy. First published: 11 April 2022
-
Autoantibodies in COVID-19 correlate with anti-viral humoral responses and distinct immune signatures
Taeschler, P., Cervia, C., Zurbuchen, Y., et al. Allergy. First published: 01 April 2022
-
Vaccine based on folded RBD-PreS fusion protein with potential to induce sterilizing immunity to SARS-CoV-2 variants
Gattinger, P., Kratzer, B., Tulaeva, I., et al. Allergy. First published: 31 March 2022
-
Humoral immune response of Sinopharm/BBIBP COVID-19 vaccination before and after the booster immunization
Cheng, Z.J., Huang, H., Zheng, P., et al. Allergy. First published: 07 March 2022
-
Interdependencies of cellular and humoral immune responses in heterologous and homologous SARS-CoV-2 vaccination
Hollstein, M.M., Münsterkötter, L., Schön, M.P., et al. Allergy. First published: 06 February 2022
-
Characterization of eosinophilic esophagitis variants by clinical, histological and molecular analyses: A cross-sectional multi-center study
Greuter, T., Straumann, A., Fernandez-Marrero, Y., et al. Allergy. First published: 29 January 2022
-
Longitudinal analyses of development of the immune system during the first five years of life in relation to lifestyle
Olin, A., Acevedo, N., Lakshmikanth, T., et al. Allergy. First published: 29 January 2022
-
Serological testing for SARS-CoV-2 antibodies in clinical practice: a comparative diagnostic accuracy study
Horn, M.P., Jonsdottir, H.R., Brigger, D., et al. Allergy. First published: 05 January 2022
-
Understanding uncontrolled severe allergic asthma by integration of omic and clinical data
Delgado-Dolset, MI, Obeso, D, Rodríguez-Coira, J, et al. Allergy. First published: 28 November 2021
-
Isolation of nanobodies with potential to reduce patients´ IgE binding to Bet v 1 (68/100 characters)
Zettl, I., Ivanova, T., Strobl, M.R., Weichwald, C., et al. Allergy. First published: 27 November 2021
-
Analysis of BNT162b2- and CVnCoV-elicited sera and of convalescent sera toward SARS-CoV-2 viruses
Hein, S, Herrlein, M-L, Mhedhbi, I, et al. Allergy.First published: 25 November 2021
-
Mapping the food allergy quality of life questionnaire parent form onto the Short-Form Six-Dimensions 2
Watts, Y., Dufresne, É., Samaan, K., Graham, F., et al. Allergy. First published: 25 November 2021
-
Measurement of IgE to hazelnut allergen components cannot replace hazelnut challenge in Dutch adults
Lyons, SA, J.Welsing, PM, Hakobyan, M, et al. Allergy. First published: 03 November 2021
-
Development and validation of the food allergy severity score
Fernández-Rivas, M, Gómez García, I, Gonzalo-Fernández, A, et al. Allergy. First published: 30 October 2021
-
Enrichment of infant formula with long-chain polyunsaturated fatty acids and risk of infection and allergy in the nationwide ELFE birth cohort
Adjibade, M., Davisse-Paturet, C., Bernard, J.Y., et al. Allergy. First published: 09 October 2021
-
Large-scale provocation studies identify maladaptive responses to ubiquitous aeroallergens as a correlate of severe allergic rhinoconjunctivitis and asthma
Smith, A.M., Ramirez, R.M., Harper, N., et al. Allergy. First published: 04 October 2021
-
Patients with systemic sclerosis show phenotypic and functional defects in neutrophils
Impellizzieri, D, Egholm, C, Valaperti, A, Distler, O, Boyman, O. Allergy.First published: 01 September 2021
-
Neutralization of SARS-CoV-2 requires antibodies against conformational receptor-binding domain epitopes
Gattinger, P., Niespodziana, K., Stiasny, K., et al. Allergy.First published: 28 August 2021
-
Evolution and long-term outcomes of combined immunodeficiency due to CARMIL2 deficiency
Kolukisa, B., Baser, D., Akcam, B., et al. Allergy.First published: 20 July 2021
-
Antibody response after one and two jabs of the BNT162b2 vaccine in nursing home residents: The CONsort-19 study
Blain, H., Tuaillon, E., Gamon, L., et al. Allergy.First published: 19 July 2021
-
The maternal diet index in pregnancy is associated with offspring allergic diseases: the Healthy Start study
Venter, C, Palumbo, MP, Glueck, DH, et al.Allergy. First published: 22 May 2021
-
Accurate and reproducible diagnosis of peanut allergy using epitope mapping
Suárez-Fariñas, M, Suprun, M, Kearney, P, et al. Allergy. First published: 15 May 2021
-
Development and validation of combined symptom-medication scores for allergic rhinitis
Sousa-Pinto, B., Filipe Azevedo, L., Jutel, M., et al. Allergy. First published: 21 December 2021
-
Overcoming bacteriophage insensitivity in staphylococcus aureus using clindamycin and azithromycinat subinhibitory concentrations
Liu, S., Zhao, Y., Hayes, A., Allergy. 2021; 76: 3446-3458
-
Profound dysregulation of T cell homeostasis and function in patients with severe COVID-19
Adamo, S., Chevrier, S., Cervia, C., et al. Allergy.2021; 76: 2866-2881
-
Prevalence and early-life risk factors of school-age allergic multimorbidity: The EuroPrevall-iFAAM birth cohort
Sigurdardottir, ST, Jonasson, K, Clausen, M, et al. Allergy. 2021; 76: 2855– 2865
-
Gene therapy for a murine model of eosinophilic esophagitis
Camilleri, A.E., Nag, S., Russo, A.R., Stiles, K.M., Crystal, R.G. and Pagovich, O.E. Allergy. 2021; 76: 2740-2752
-
Single-dose prolonged drug provocation test, without previous skin testing, is safe for diagnosing children with mild non-immediate reactions to beta-lactams
Prieto, A., Muñoz, C., Bogas, G., et al. Allergy.2021; 76: 2544-2554
-
Tear N-glycomics in vernal and atopic keratoconjunctivitis
Messina, A., Palmigiano, A., Tosto, C., et al. Allergy.2021; 76: 2500-2509
-
Breastfeeding promotes early neonatal regulatory T-cell expansion and immune tolerance of non-inherited maternal antigens
Wood, H., Acharjee, A., Pearce, H., et al. Allergy.2021; 76: 2447-2460
-
Orofacial granulomatosis: Clinical and therapeutic features in an Italian cohort and review of the literature
Galdiero, M.R., Maio, F., Arcoleo, F., et al. Allergy.2021; 76: 2189-2200
-
Childhood vaccination and allergy: A systematic review and meta-analysis
Navaratna, S., Estcourt, M.J., Burgess, J., et al. Allergy.2021; 76: 2135-2152
-
Elastase and exacerbation of neutrophil innate immunity are involved in multi-visceral manifestations of COVID-19
Guéant, J.-L., Guéant-Rodriguez, R.-M., Fromonot, J., et al. Allergy. 2021; 76: 1846-1858
-
Basophil activation test shows high accuracy in the diagnosis of peanut and tree nut allergy: The markers of nut allergy study
Duan, L, Celik, A, Hoang, JA, et al. Allergy. 2021; 76: 1800– 1812.
-
Digital technology for anaphylaxis management impact on patient behaviour: A randomized clinical trial
Sala-Cunill, A, Luengo, O, Curran, A, et al. Allergy. 2021; 76: 1507– 1516
-
Diagnosing, managing and preventing anaphylaxis: Systematic review
de Silva, D, Singh, C, Muraro, A, et al. Allergy. 2021; 76: 1493– 1506
-
Food-dependent NSAID-induced hypersensitivity (FDNIH) reactions: Unraveling the clinical features and risk factors
Sánchez-López, J, Araujo, G, Cardona, V, et al. Allergy. 2021; 76: 1480– 1492
-
Predicting food allergy: The value of patient history reinforced
Lyons, SA, Knulst, AC, Burney, PGJ, et al. Allergy. 2021; 76: 1454– 1462
-
Predicting persistence of atopic dermatitis in children using clinical attributes and serum proteins
Lauffer, F, Baghin, V, Standl, M, et al. Allergy. 2021; 76: 1158– 1172
-
Accuracy of serological testing for SARS-CoV-2 antibodies: First results of a large mixed-method evaluation study
Brigger, D, Horn, MP, Pennington, LF, et al. Allergy. 2021; 76: 853– 865
-
Diagnostic workup including CD203c-based basophil activation test in immediate hypersensitivity due to metronidazole and ornidazole and evaluation of cross-reactivity in between
Beyaz, Ş, Akdeniz, N, Yılmaz, A, et al. Allergy. 2021; 76: 842– 852
-
Modeling the conversion between specific IgE test platforms for nut allergens in children and adolescents
Hoang, JA, Celik, A, Lupinek, C, et al. et al. Allergy. 2021; 76: 831– 841
-
Antibody dynamics to SARS-CoV-2 in asymptomatic COVID-19 infections
Lei, Q, Li, Y, Hou, H-Y, et al. Allergy. 2021; 76: 551– 561
-
Short-Form Six-Dimensions version 2 preference value set for health utility in food allergy
Dufresne E., Poder, T.G., Samaan, K. et al. Allergy. 2021; 76: 326-228
-
APPEAL-1: A pan-European survey of patient/caregiver perceptions of peanut allergy management
Blumchen, K, DunnGalvin, A, Timmermans, F, et al. Allergy. 2020; 75: 2920– 2935
-
APPEAL-1: A multiple-country European survey assessing the psychosocial impact of peanut allergy
DunnGalvin, A, Blumchen, K, Timmermans, F, et al. Allergy. 2020; 75: 2899– 2908
-
Quality of life of children aged 8-12 years undergoing food allergy oral immunotherapy: Child and parent perspective
Epstein-Rigbi, N, Goldberg, MR, Levy, MB, Nachshon, L, Elizur, A. et al. Allergy. 2020; 75: 2623– 2632
-
IgE to epitopes of Ara h 2 enhance the diagnostic accuracy of Ara h 2-specific IgE
Santos, AF, Barbosa-Morais, NL, Hurlburt, BK, et al. Allergy. 2020; 75: 2309– 2318
-
Orally applied bacterial lysate in infants at risk for atopy does not prevent atopic dermatitis, allergic rhinitis, asthma or allergic sensitization at school age: Follow-up of a randomized trial
Roßberg, S, Keller, T, Icke, K, et al. Allergy. 2020; 75: 2020– 2025
-
Clinical features and survival of patients with indolent systemic mastocytosis defined by the updated WHO classification
Trizuljak, J, Sperr, WR, Nekvindová, L, et al. Allergy. 2020; 75: 1927– 1938
-
Data-driven step doses for drug provocation tests to nonsteroidal anti-inflammatory drugs
Nohra, D, Molinari, N, Demoly, P, Chiriac, A-M. Allergy. 2020; 75: 1423– 1434
-
Development of the angioedema control test-A patient-reported outcome measure that assesses disease control in patients with recurrent angioedema
Weller, K, Donoso, T, Magerl, M, et al. Allergy. 2020; 75: 1165– 1177
-
The role of drug, dose, and the tolerance/intolerance of new drugs in multiple drug hypersensitivity syndrome
Jörg, L, Yerly, D, Helbling, A, Pichler, W. Allergy. 2020; 75: 1178– 1187
-
ILC3 deficiency and generalized ILC abnormalities in DOCK8-deficient patients
Eken, A, Cansever, M, Okus, FZ, et al. Allergy. 2020; 75: 921– 932
-
Secondary prevention measures in anaphylaxis patients: Data from the anaphylaxis registry
Kraft, M, Knop, MP, Renaudin, J-M, et al. Allergy. 2020; 75: 901– 910
-
Biomarkers and clinical characteristics of autoimmune chronic spontaneous urticaria: Results of the PURIST Study
Schoepke, N, Asero, R, Ellrich, A, et al. Allergy. 2019; 74: 2427– 2436
-
Clinical factors associated with peanut allergy in a high-risk infant cohort
Sicherer, SH, Wood, RA, Perry, TT, et al. Allergy. 2019; 74: 2199– 2211
-
Large local reactions to Hymenoptera stings: Outcome of re-stings in real life
ilò, MB, Martini, M, Pravettoni, V, et al. Allergy. 2019; 74: 1969– 1976
-
Safety and reproducibility of nasal allergen challenge
Eguiluz-Gracia, I, Testera-Montes, A, González, M, et al. Allergy. 2019; 74: 1125– 1134
-
Gene therapy for C1 esterase inhibitor deficiency in a murine model of hereditary angioedema
Qiu, T, Chiuchiolo, MJ, Whaley, AS, et al. Allergy. 2019; 74: 1081– 1089
-
Active vaccination against interleukin-5 as long-term treatment for insect-bite hypersensitivity in horses
Fettelschoss-Gabriel, A, Fettelschoss, V, Olomski, F, et al. Allergy. 2019; 74: 572– 582
-
Quantitative profiling of cytokines and chemokines in DOCK8-deficient and atopic dermatitis patients
Jacob, M, Bin Khalaf, D, Alhissi, S, et al. Allergy. 2019; 74: 370– 379